The effects of haemodialysis and peritoneal dialysis on serum lipoprotein(a) and C-reactive protein levels

被引:15
作者
Borazan, A
Üstün, H
Yilmaz, A
机构
[1] Zonguldak Karelmas Univ, Fac Internal Med, Zonguldak, Turkey
[2] Kocaeli Univ, Fac Internal Med, Dept Med Oncol, Kocaeli, Turkey
[3] Kocaeli Univ, Fac Internal Med, Dept Nephrol, Kocaeli, Turkey
关键词
haemodialysis; continuous ambulatory peritoneal dialysis; lipoprotein(a); C-reactive protein;
D O I
10.1177/147323000303100504
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Elevated serum lipoprotein(a) is an independent risk factor for coronary artery disease, and C-reactive protein (CRP) is a general and cardiovascular marker in haemodialysis patients. We studied lipoprotein(a) and CRP levels in 48 haemodialysis and 24 continuous ambulatory peritoneal dialysis (CAPD) patients and 20 healthy individuals, after a 12 h fast. Serum lipoprotein(a) levels were elevated in 31.3%, 66.7% and 5% of haemodialysis and CAPD patients and control subjects, respectively. The difference between all groups was significant. Serum CRP levels were high in 43.8%, 58.4% and 5% of haemodialysis and CAPD patients, and healthy subjects, respectively. The mean serum CRP level was significantly different between all groups. Both protein levels were higher in CAPD patients than haemodialysis patients, suggesting that CAPD patients should be more closely monitored for coronary artery disease.
引用
收藏
页码:378 / 383
页数:6
相关论文
共 19 条
[1]   Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis [J].
Chung, SH ;
Heimbürger, O ;
Stenvinkel, P ;
Bergström, J ;
Lindholm, B .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (11) :2240-2245
[2]   OCCURRENCE AND SIGNIFICANCE OF HEART-DISEASE IN UREMIA - AN AUTOPSY STUDY [J].
CLYNE, N ;
LINS, LE ;
PEHRSSON, SK .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1986, 20 (04) :307-311
[3]   Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose [J].
Heimburger, O ;
Stenvinkel, P ;
Berglund, L ;
Tranaeus, A ;
Lindholm, B .
NEPHRON, 1996, 72 (02) :135-144
[4]   Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients [J].
Iseki, K ;
Tozawa, M ;
Yoshi, S ;
Fukiyama, K .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (08) :1956-1960
[5]   The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients [J].
Kaysen, GA ;
Dubin, JA ;
Müller, HG ;
Rosales, LM ;
Levin, NW .
KIDNEY INTERNATIONAL, 2000, 58 (01) :346-352
[6]   Determinants of albumin concentration in hemodialysis patients [J].
Kaysen, GA ;
Stevenson, FT ;
Depner, TA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (05) :658-668
[7]  
Kronenberg F, 2000, J AM SOC NEPHROL, V11, P105, DOI 10.1681/ASN.V111105
[8]   ACCELERATED ATHEROSCLEROSIS IN PROLONGED MAINTENANCE HEMODIALYSIS [J].
LINDNER, A ;
CHARRA, B ;
SHERRARD, DJ ;
SCRIBNER, BH .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (13) :697-701
[9]   C-reactive protein as an outcome predictor for maintenance hemodialysis patients [J].
Owen, WF ;
Lowrie, EG .
KIDNEY INTERNATIONAL, 1998, 54 (02) :627-636
[10]   Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men [J].
Rohde, LEP ;
Hennekens, CH ;
Ridker, PM .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (09) :1018-1022